EYEPOINT PHARMACEUTICALS, INC Current Ratio 2006-2021 | EYPT

EYEPOINT PHARMACEUTICALS, INC current ratio from 2006 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
EYEPOINT PHARMACEUTICALS, INC Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.15B $0.02B 9.34
2021-03-31 $0.16B $0.01B 11.86
2020-12-31 $0.06B $0.02B 4.24
2020-09-30 $0.05B $0.01B 3.68
2020-06-30 $0.04B $0.01B 4.16
2020-03-31 $0.05B $0.01B 4.83
2019-12-31 $0.04B $0.01B 3.62
2019-09-30 $0.05B $0.01B 4.54
2019-06-30 $0.06B $0.01B 5.46
2019-03-31 $0.05B $0.03B 1.96
2018-12-31 $0.05B $0.02B 2.22
2018-09-30 $0.06B $0.02B 2.57
2018-06-30 $0.04B $0.02B 1.84
2018-03-31 $0.02B $0.02B 0.83
2017-12-31 $0.01B $0.00B 3.21
2017-09-30 $0.01B $0.00B 2.93
2017-06-30 $0.02B $0.01B 3.35
2017-03-31 $0.02B $0.01B 3.33
2016-12-31 $0.02B $0.01B 3.76
2016-09-30 $0.02B $0.01B 4.85
2016-06-30 $0.03B $0.01B 5.88
2016-03-31 $0.03B $0.00B 8.64
2015-12-31 $0.02B $0.00B 5.63
2015-09-30 $0.03B $0.00B 8.41
2015-06-30 $0.03B $0.00B 8.91
2015-03-31 $0.03B $0.00B 14.91
2014-12-31 $0.04B $0.00B 16.43
2014-09-30 $0.04B $0.00B 17.60
2014-06-30 $0.02B $0.00B 9.10
2014-03-31 $0.02B $0.00B 9.87
2013-12-31 $0.02B $0.00B 8.01
2013-09-30 $0.02B $0.00B 6.69
2013-06-30 $0.01B $0.00B 3.77
2013-03-31 $0.02B $0.00B 5.66
2012-12-31 $0.02B $0.00B 8.07
2012-09-30 $0.02B $0.00B 5.46
2012-06-30 $0.02B $0.00B 5.02
2012-03-31 $0.02B $0.00B 6.91
2011-12-31 $0.02B $0.00B 7.54
2011-09-30 $0.02B $0.00B 5.58
2011-06-30 $0.03B $0.01B 5.04
2011-03-31 $0.02B $0.00B 16.31
2010-12-31 $0.02B $0.00B 9.81
2010-09-30 $0.02B $0.00B 7.34
2010-06-30 $0.02B $0.00B 6.49
2010-03-31 $0.01B $0.00B 1.36
2009-12-31 $0.01B $0.00B 1.51
2009-09-30 $0.01B $0.01B 0.98
2009-06-30 $0.01B $0.01B 0.93
2009-03-31 $0.01B $0.01B 0.85
2008-12-31 $0.01B $0.01B 0.83
2008-09-30 $0.01B $0.01B 0.97
2008-06-30 $0.02B $0.02B 1.02
2008-03-31 $0.02B $0.02B 1.41
2007-12-31 $0.01B $0.01B 1.18
2007-09-30 $0.02B $0.01B 1.50
2007-06-30 $0.01B $0.02B 0.34
2007-03-31 $0.00B 0.00
2006-12-31 $0.00B 0.00
2006-09-30 $0.00B 0.00
2006-06-30 $0.01B $0.02B 0.71
2005-06-30 $0.01B $0.00B 6.81
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.346B $0.034B
EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76